Ilex Medical (ILX) - Net Assets

Latest as of June 2025: ILA660.36 Million ILA ≈ $1.77 Million USD

Based on the latest financial reports, Ilex Medical (ILX) has net assets worth ILA660.36 Million ILA (≈ $1.77 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA947.26 Million ≈ $2.54 Million USD) and total liabilities (ILA286.90 Million ≈ $769.17K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ILX asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA660.36 Million
% of Total Assets	69.71%
Annual Growth Rate	11.74%
5-Year Change	45.76%
10-Year Change	186.07%
Growth Volatility	33.39

Ilex Medical - Net Assets Trend (2008–2024)

This chart illustrates how Ilex Medical's net assets have evolved over time, based on quarterly financial data. Also explore Ilex Medical asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Ilex Medical (2008–2024)

The table below shows the annual net assets of Ilex Medical from 2008 to 2024. For live valuation and market cap data, see ILX stock market capitalisation.

Year	Net Assets	Change
2024-12-31	ILA646.49 Million ≈ $1.73 Million	+3.69%
2023-12-31	ILA623.51 Million ≈ $1.67 Million	+1.70%
2022-12-31	ILA613.10 Million ≈ $1.64 Million	+6.52%
2021-12-31	ILA575.57 Million ≈ $1.54 Million	+29.77%
2020-12-31	ILA443.54 Million ≈ $1.19 Million	+37.12%
2019-12-31	ILA323.48 Million ≈ $867.23K	+10.22%
2018-12-31	ILA293.49 Million ≈ $786.83K	+10.27%
2017-12-31	ILA266.15 Million ≈ $713.53K	+8.85%
2016-12-31	ILA244.51 Million ≈ $655.52K	+8.19%
2015-12-31	ILA225.99 Million ≈ $605.87K	+10.45%
2014-12-31	ILA204.60 Million ≈ $548.53K	-4.56%
2013-12-31	ILA214.38 Million ≈ $574.74K	-17.53%
2012-12-31	ILA259.96 Million ≈ $696.93K	-8.14%
2011-12-31	ILA282.99 Million ≈ $758.68K	+134.26%
2010-12-31	ILA120.80 Million ≈ $323.87K	-5.12%
2009-12-31	ILA127.32 Million ≈ $341.33K	+16.33%
2008-12-31	ILA109.44 Million ≈ $293.42K	--

Equity Component Analysis

This analysis shows how different components contribute to Ilex Medical's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 520.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	ILA568.58 Million	87.95%
Other Components	ILA77.91 Million	12.05%
Total Equity	ILA646.49 Million	100.00%

Ilex Medical Competitors by Market Cap

The table below lists competitors of Ilex Medical ranked by their market capitalization.

Company	Market Cap
BriQ Properties Real Estate Investment Company AT:BRIQ	$141.32 Million
HIM International Music TWO:8446	$141.37 Million
Whitehawk Therapeutics, Inc. NASDAQ:WHWK	$141.39 Million
Kotra Industries Bhd KLSE:0002	$141.50 Million
TRUFIN PLC F:29U	$141.30 Million
Dmc Global Inc NASDAQ:BOOM	$141.23 Million
Lindsay Australia Ltd AU:LAU	$141.23 Million
Proficient Auto Logistics, Inc. Common Stock NASDAQ:PAL	$141.12 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ilex Medical's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 623,506,000 to 646,487,000, a change of 22,981,000 (3.7%).
Net income of 38,981,000 contributed positively to equity growth.
Dividend payments of 15,266,000 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	ILA38.98 Million	+6.03%
Dividends Paid	ILA15.27 Million	-2.36%
Other Changes	ILA-734.00K	-0.11%
Total Change	ILA-	3.69%

Book Value vs Market Value Analysis

This analysis compares Ilex Medical's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 81.53x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 249.04x to 81.53x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2018-12-31	ILA18.92	ILA4711.00	x
2019-12-31	ILA22.20	ILA4711.00	x
2020-12-31	ILA39.32	ILA4711.00	x
2021-12-31	ILA51.02	ILA4711.00	x
2022-12-31	ILA54.35	ILA4711.00	x
2023-12-31	ILA55.27	ILA4711.00	x
2024-12-31	ILA57.78	ILA4711.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ilex Medical utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.03%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 4.24%
• Asset Turnover: 0.93x
• Equity Multiplier: 1.54x
Recent ROE (6.03%) is below the historical average (18.69%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	17.00%	8.75%	1.25x	1.55x	ILA7.67 Million
2009	23.66%	12.30%	1.27x	1.52x	ILA17.39 Million
2010	23.88%	11.67%	1.29x	1.59x	ILA16.77 Million
2011	23.36%	7.60%	0.63x	4.91x	ILA18.71 Million
2013	-25.66%	-4.81%	0.86x	6.17x	ILA-30.87 Million
2014	24.05%	5.11%	0.85x	5.51x	ILA12.91 Million
2015	25.99%	6.25%	1.03x	4.02x	ILA19.14 Million
2016	19.60%	5.33%	1.06x	3.46x	ILA13.54 Million
2017	23.04%	6.76%	1.14x	2.99x	ILA21.17 Million
2018	24.75%	7.82%	1.13x	2.81x	ILA28.00 Million
2019	27.05%	9.50%	1.09x	2.61x	ILA37.98 Million
2020	27.20%	12.74%	1.21x	1.76x	ILA76.27 Million
2021	34.31%	18.61%	1.21x	1.52x	ILA139.92 Million
2022	16.66%	11.70%	0.97x	1.47x	ILA40.81 Million
2023	8.16%	5.55%	0.90x	1.63x	ILA-11.47 Million
2024	6.03%	4.24%	0.93x	1.54x	ILA-25.67 Million

Industry Comparison

This section compares Ilex Medical's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $30,638,556
Average return on equity (ROE) among peers: -58.34%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Ilex Medical (ILX)	ILA660.36 Million	17.00%	0.43x	$141.31 Million
Allmed Solutions Ltd (ALMD)	$14.19 Million	-44.58%	0.09x	$8.53 Million
Erika Carmel Ltd (BCUR)	$23.73 Million	-81.01%	0.98x	$4.69 Million
Bio-View Ltd (BIOV)	$25.07 Million	3.53%	0.35x	$4.83 Million
Brainsway Ltd (BWAY)	$15.58 Million	-42.02%	0.65x	$463.07 Million
Erech Finance Cahalacha Ltd (EFNC)	$-63.00K	0.00%	0.00x	$1.74 Million
Epitomee Medical Ltd (EPIT)	$34.80 Million	-16.33%	0.16x	$62.09 Million
Erika Carmel-Tech Ltd (ERKA)	$9.79 Million	-59.80%	1.98x	$5.82 Million
Human Xtensions Ltd (HUMX)	$20.43 Million	-240.60%	1.15x	$2.12 Million
Pulsenmore Ltd (PULS)	$132.23 Million	-44.29%	0.36x	$22.89 Million

About Ilex Medical

TA:ILX Israel Medical Devices

Market Cap

$141.31 Million

ILA52.71 Billion ILA

Market Cap Rank

#17948 Global

#230 in Israel

Share Price

ILA4711.00

Change (1 day)

+1.53%

52-Week Range

ILA4620.00 - ILA7080.00

All Time High

ILA15645.73